Lenox Wealth Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-300
Closed -$1K 654
2020
Q3
$1K Hold
300
﹤0.01% 558
2020
Q2
$1K Hold
300
﹤0.01% 563
2020
Q1
$1K Hold
300
﹤0.01% 715
2019
Q4
$2K Hold
300
﹤0.01% 618
2019
Q3
$2K Hold
300
﹤0.01% 520
2019
Q2
$2K Hold
300
﹤0.01% 363
2019
Q1
$2K Hold
300
﹤0.01% 538
2018
Q4
$2K Hold
300
﹤0.01% 340
2018
Q3
$5K Hold
300
﹤0.01% 313
2018
Q2
$4K Sell
300
-500
-63% -$8.45K ﹤0.01% 473
2018
Q1
$12K Buy
+800
New +$11.4K ﹤0.01% 339

Other funds holding PGEN

Lenox Wealth Advisors's PGEN Position: Q4 2020 in Review

Lenox Wealth Advisors sold out of Precigen (PGEN) in Q4 2020, closing a stake of 300 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in PGEN in Q1 2018 and held it in 11 quarters. The position peaked at $12K in Q1 2018. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

  • Lenox Wealth Advisors reported no remaining Precigen position as of Q4 2020 after selling out during the quarter.
  • Lenox Wealth Advisors sold 300 Precigen shares in Q4 2020, an estimated $1K.
  • Lenox Wealth Advisors first reported a position in Precigen in Q1 2018 and held it in 11 quarters.
  • Lenox Wealth Advisors's Precigen position peaked at $12K in Q1 2018.
  • 151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on Lenox Wealth Advisors's 13F filing for Q4 2020, filed 19 Jan 2021.